Tapinarof - 99%, high purity , Aryl hydrocarbon receptor agonist, CAS No.79338-84-4, Aryl hydrocarbon receptor agonist

Item Number
T414465
Grouped product items
SKUSizeAvailabilityPrice Qty
T414465-25mg
25mg
In stock
$244.90
T414465-100mg
100mg
In stock
$815.90
T414465-250mg
250mg
In stock
$1,414.90
T414465-1g
1g
In stock
$5,094.90

AhR Agonists

Basic Description

Synonyms5-((1E)-2-PHENYLETHEN-1-YL)-2-(PROPAN-2-YL)BENZENE-1,3-DIOL | Tapinarof (USAN) | 5-[(1E)-2-Phenylethen-1-yl]-2-(propan-2-yl)benzene-1,3-diol | GTPL9686 | AKOS025296109 | s9700 | TAPINAROF [INN] | BCP13569 | Sinefunginum [INN-Latin] | 2-Isopropyl-5-styrylb
Specifications & PurityMoligand™, ≥99%
Biochemical and Physiological MechanismsTapinarof (GSK2894512, Benvitimod, WBI 1001, DHPS, DMVT 505) is a natural agonist of aryl hydrocarbon receptor (AhR) and induces nuclear translocation of AhR in immortalized keratinocytes (HaCaT) with EC50 of 0.16 nM. Tapinarof induces cellular apoptosis
Storage TempProtected from light,Store at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeAGONIST
Mechanism of actionAryl hydrocarbon receptor agonist
Product Description

Information

Tapinarof Tapinarof (GSK2894512, Benvitimod, WBI 1001, DHPS, DMVT 505) is a natural agonist of aryl hydrocarbon receptor (AhR) and induces nuclear translocation of AhR in immortalized keratinocytes (HaCaT) with EC50 of 0.16 nM. Tapinarof induces cellular apoptosis in CD4+ T cells in a dosedependent manner with IC50 of 5.2 μM.


Targets

AhR (in immortalized keratinocytes); apoptosis (in CD4+ T cells) 0.16 nM(EC50); 5.2 μM


In vitro

Tapinarof binds and activates AhR in multiple cell types, including cells of the target tissue –human skin. In addition, tapinarof moderates proinflammatory cytokine expression in stimulated peripheral blood CD4+ T cells and ex vivo human skin, and impacts barrier gene expression in primary human keratinocytes; both of these processes are likely to be downstream of AhR activation based on current evidence.


In vivo

The anti-inflammatory properties of tapinarof derive from AhR agonism is conclusively demonstrated using the mouse model of imiquimod-induced psoriasiform skin lesions. Topical treatment of AhR-sufficient mice with tapinarof leads to compound-driven reductions in erythema, epidermal thickening and tissue cytokine levels. In contrast, tapinarof has no impact on imiquimod-induced skin inflammation in AhR-deficient mice.


Cell Research(from reference)

Cell lines:HaCaT cells 

Concentrations:0.01 pM - 1 μM 

Incubation Time:30 min 

Product Properties

ALogP4.526
HBD Count2
Rotatable Bond3

Associated Targets(Human)

AHR Tclin Aryl hydrocarbon receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AHR Tclin Aryl hydrocarbon receptor (1071 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Saccharomyces cerevisiae (19171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Manduca sexta (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caenorhabditis elegans (1055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hemolymph (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ProPO Prophenoloxidase (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Photorhabdus luminescens (66 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name 5-[(E)-2-phenylethenyl]-2-propan-2-ylbenzene-1,3-diol
INCHI InChI=1S/C17H18O2/c1-12(2)17-15(18)10-14(11-16(17)19)9-8-13-6-4-3-5-7-13/h3-12,18-19H,1-2H3/b9-8+
InChi Key ZISJNXNHJRQYJO-CMDGGOBGSA-N
Canonical SMILES CC(C)C1=C(C=C(C=C1O)C=CC2=CC=CC=C2)O
Isomeric SMILES CC(C)C1=C(C=C(C=C1O)/C=C/C2=CC=CC=C2)O
PubChem CID 6439522
Molecular Weight 254.32

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

8 results found

Lot NumberCertificate TypeDateItem
F23061212Certificate of AnalysisApr 17, 2023 T414465
F23061244Certificate of AnalysisApr 17, 2023 T414465
F23061305Certificate of AnalysisApr 17, 2023 T414465
F23061329Certificate of AnalysisApr 17, 2023 T414465
F23061339Certificate of AnalysisApr 17, 2023 T414465
F23061400Certificate of AnalysisApr 17, 2023 T414465
F23061413Certificate of AnalysisApr 17, 2023 T414465
F23061415Certificate of AnalysisApr 17, 2023 T414465

Chemical and Physical Properties

SolubilitySolubility (25°C) In vitro DMSO: 51 mg/mL (200.53 mM); Ethanol: 51 mg/mL (200.53 mM); Water: Insoluble;
SensitivityLight sensitive
DMSO(mg / mL) Max Solubility51
DMSO(mM) Max Solubility200.534759358289
Water(mg / mL) Max Solubility<1

Safety and Hazards(GHS)

Pictogram(s) GHS09
Signal Warning
Hazard Statements

H400:Very toxic to aquatic life

H410:Very toxic to aquatic life with long lasting effects

Precautionary Statements

P273:Avoid release to the environment.

P501:Dispose of contents/container to ...

P391:Collect spillage.

Related Documents

References

1. Bissonnette R, Bolduc C, Maari C, Nigen S, Webster JM, Tang L, Lyle M.  (2012)  Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial..  J Eur Acad Dermatol Venereol,  26  (12): (1516-21).  [PMID:22077962] [10.1021/op500134e]
2. Smith SH, Jayawickreme C, Rickard DJ, Nicodeme E, Bui T, Simmons C, Coquery CM, Neil J, Pryor WM, Mayhew D et al..  (2017)  Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans..  J Invest Dermatol,  137  (10): (2110-2119).  [PMID:28595996] [10.1021/op500134e]
3. Lebwohl MG, Stein Gold L, Strober B, Papp KA, Armstrong AW, Bagel J, Kircik L, Ehst B, Hong HC, Soung J et al..  (2021)  Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis..  N Engl J Med,  385  (24): (2219-2229).  [PMID:34879448] [10.1021/op500134e]

Solution Calculators